Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,731 | -8,237 | -29,931 | -41,879 | -28,706 |
| Depreciation Amortization | N/A | N/A | N/A | 3,163 | 1,076 |
| Accounts receivable | -1,319 | 1,374 | -2,402 | N/A | N/A |
| Accounts payable and accrued liabilities | 381 | 1,330 | N/A | N/A | N/A |
| Other Working Capital | -425 | 2,847 | -4,764 | 5,472 | 2,398 |
| Other Operating Activity | 1,184 | -13,754 | 10,124 | 5,964 | 5,197 |
| Operating Cash Flow | $-10,910 | $-16,440 | $-26,972 | $-27,280 | $-20,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -3,131 | -9,253 |
| Other Investing Activity | 0 | 18,664 | -4,945 | 0 | 0 |
| Investing Cash Flow | $N/A | $18,664 | $-4,945 | $-3,131 | $-9,253 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,991 | 1,105 | 202 | 52,556 | 6,736 |
| Financing Cash Flow | $14,991 | $1,105 | $202 | $52,556 | $6,736 |
| Beginning Cash Position | 15,112 | 11,782 | 43,497 | 21,352 | 43,904 |
| End Cash Position | 19,192 | 15,112 | 11,782 | 43,497 | 21,352 |
| Net Cash Flow | $4,081 | $3,329 | $-31,715 | $22,145 | $-22,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,910 | -16,440 | -26,972 | -27,280 | -20,035 |
| Capital Expenditure | N/A | N/A | N/A | -3,131 | -9,253 |
| Free Cash Flow | -10,910 | -16,440 | -26,972 | -30,411 | -29,288 |